APA (7th ed.) Citation

Aida Iraji, Ali Nemati, Hona Hosseinpoor, Najmeh Edraki, mahsima Khoshneviszadeh, Mahshid Attarroshan, . . . Mehdi Khoshneviszadeh. (2020). Novel heterocyclic hybrid of 2-(aryl)-1H-indene-1,3(2H)-dione targeting tyrosinase: Design, biological evaluation and in silico studies. Shiraz University of Medical Sciences.

Chicago Style (17th ed.) Citation

Aida Iraji, Ali Nemati, Hona Hosseinpoor, Najmeh Edraki, mahsima Khoshneviszadeh, Mahshid Attarroshan, Hossein Sadeghpour, and Mehdi Khoshneviszadeh. Novel Heterocyclic Hybrid of 2-(aryl)-1H-indene-1,3(2H)-dione Targeting Tyrosinase: Design, Biological Evaluation and in Silico Studies. Shiraz University of Medical Sciences, 2020.

MLA (9th ed.) Citation

Aida Iraji, et al. Novel Heterocyclic Hybrid of 2-(aryl)-1H-indene-1,3(2H)-dione Targeting Tyrosinase: Design, Biological Evaluation and in Silico Studies. Shiraz University of Medical Sciences, 2020.